<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The identification of etiological factors in the induction of <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> has remained elusive despite an enormous effort at dissection of the molecular structure of the target antigens and effector mechanisms </plain></SENT>
<SENT sid="1" pm="."><plain>One characteristic feature of autoantigens is their repetitive structure as well as their conservation and evolution </plain></SENT>
<SENT sid="2" pm="."><plain>Toxoplasma (T.) gondii is a primitive protozoan </plain></SENT>
<SENT sid="3" pm="."><plain>We hypothesized that patients with <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> would have broad reactions against Toxoplasma antigens based on autoantigen conservation </plain></SENT>
<SENT sid="4" pm="."><plain>To address this issue, we assessed serologic evidence of reactivity to Toxoplasma gondii along with a large profile of autoantibodies in patients with various <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> (AID) </plain></SENT>
<SENT sid="5" pm="."><plain>We included sera of 1514 patients with 11 different AID collected from referral centers in Europe and Latin America as well as from 437 geographically matched controls, for the prevalence of anti Toxoplasma antibodies (ATxA) IgG and IgM and serum autoantibodies utilizing the BioPlex 2200 system (Bio- Rad Laboratories, USA) </plain></SENT>
<SENT sid="6" pm="."><plain>Serum ATxA IgG were positive in 42% of patients with AID versus 29% of controls (p &lt; 0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>Among Europeans, ATxA IgG were associated with anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome (APS; p &lt; 0.0001), <z:hpo ids='HP_0100778'>cryoglobulinemia</z:hpo> (p &lt; 0.0001), <z:chebi fb="0" ids="34507">ANCA</z:chebi>-associated <z:e sem="disease" ids="C0042384" disease_type="Disease or Syndrome" abbrv="">vasculitides</z:e> (p &lt; 0.01), autoimmune <z:hpo ids='HP_0000820'>thyroid diseases</z:hpo> (p &lt; 0.0001), systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> (SSc; p &lt; 0.0001) and <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (RA; p &lt; 0.0001) </plain></SENT>
<SENT sid="8" pm="."><plain>Of note, Latin American RA sera exhibited similar frequency of ATxA IgG as controls </plain></SENT>
<SENT sid="9" pm="."><plain>ATxA IgM were more prevalent in European patients with APS (p &lt; 0.01), SSc (p &lt; 0.05) and <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD, p &lt; 0.05) than in controls </plain></SENT>
<SENT sid="10" pm="."><plain>Further, in AID patients the presence of ATxA correlated with autoantibodies characteristic of APS (anti- <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>, B2GPI, complex of <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>- B2GPI, prothrombin, phosphatydilethanolamine), and of SSc (anti-centromere, Scl-70) </plain></SENT>
<SENT sid="11" pm="."><plain>Our findings suggest that T. gondii may contribute to the pathogenesis of AID </plain></SENT>
<SENT sid="12" pm="."><plain>This interaction may depend on or explain observed geoepidemiological variance in AID </plain></SENT>
</text></document>